Expression of Erythroid-Specific Genes in Megakaryoblastic Disorders

References

• Koike T. Megakaryocytic leukemia: The characterization and identification of megakaryoblasts. Blood 1984; 64: 683–692
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage. Annals of Internal Medicine 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Martin D. I. K., Zon L. I., Mutter G., Orkin S. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature 1990; 344: 444–447
   PubMed Web of Science ®Google Scholar
• Romeo P. H., Prandini M. H., Joulin V., Mignoffe V., Prenent M., Vainchenker W., Marguerie G., Uzan G. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 1990; 344: 447–449
   PubMed Web of Science ®Google Scholar
• Suda T., Suda J., Ogawa M. (1978) Single cell origin of mouse hematopoietic colonies expressing multiple lineages in variable combinations. Proceedings of the National Academy of Science of the United States of America 1983; 80:6689–6693. 1983
   Google Scholar
• Lewis D. S. Association between megakaryoblastic leukemia and Down syndrome. Lancet 1981; 2: 695
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Yamamoto K. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15–23
   PubMed Web of Science ®Google Scholar
• Nagao T., Lampkin B. C., Hug G. A neonate with Down's syndrome and transient abnormal myelopoiesis: Serial blood and bone marrow studies. Blood 1970; 36: 443–447
   PubMed Web of Science ®Google Scholar
• Siebel N. L., Sommer A., Miser J. Transient neonatal leukemoid reaction in mosaic trisomy 21. J. Pediatr. 1984; 104: 251
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Down syndrome and acute leukemia: Increased risk may be due to trisomy 21. Lancet 1981; 2: 1020–1022
   PubMed Web of Science ®Google Scholar
• Morgan J., Hecht F., Cleary M. L., Sklar J., Link M. P. Leukemia with Down's syndrome: Translocation between chromosome 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 1985; 66: 1466–1468
   PubMed Web of Science ®Google Scholar
• Miyashita T., Asada M., Fujimoto J., Inaba T., Takihara Y., Sugita K., Bessho F., Furukawa T., Mizutani S. Clonal analysis of transient myeloproliferative disorder in Down's syndrome. Leukemia 1991; 5: 56–59
   PubMed Web of Science ®Google Scholar
• Kurahashi H., Hara J., Yumura-Yagi K., Murayama N., Inoue M., Ishihara S., Tawa A., Okada S., Kawa-Ha K. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood 1991; 77: 1161–1163
   PubMed Web of Science ®Google Scholar
• Andrew N. C., Erdjument-Bromage H., Davidson M. B., Tempst P., Orkin S. H. Erythroid transcription factor NF-E2 is a hematopoietic specific basic-leucine zipper protein. Nature 1993; 362: 722–728
   PubMed Web of Science ®Google Scholar
• Pevny L., Simmon M. C., Robertson E., Klein W. H., Tsai S. F., D'Agati V., Orkin S. H., Constantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991; 349: 257–260
   PubMed Web of Science ®Google Scholar
• Ito E., Toki T., Ishihara H., Ohtani H., Gu L., Yokoyama M., Engel J. D., Yamamoto M. Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 1993; 362: 466–468
   PubMed Web of Science ®Google Scholar
• Igarashi K., Kataoka K., Itoh K., Hayashi N., Nishizawa M., Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 1994; 367: 568–572
   PubMed Web of Science ®Google Scholar
• Andrews N. C., Kotkow K. J., Ney P. A., Erdjument-Bromage H., Tempest P., Orkin S. H. (1978) The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proceedings of the National Academy of Science of the United States of America 1993; 90:11488–11492. 1993
   Google Scholar
• Shivdasani R. A., Rosenblatt M. F., Zuncker-Franklin D., Jackson C. W., Hunt P., Saris C. J. M., Orkin S. H. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995; 81: 695–704
   PubMed Web of Science ®Google Scholar
• Robb L., Lyons I., Li R., Hartley L., Kontogen F., Harvey R. P., Metcalf D., Begley C. G. (1978) Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proceedings of the National Academy of Science of the United States 1995; 92:7075–7079. 1995
   Google Scholar
• Mouthon M-A., Bernard O., Mitjivila M.-T., Romeo P.-H., Vainchenker W., Mathieu-Mahul D. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 1993; 81: 647–655
   PubMed Web of Science ®Google Scholar
• Sato T., Fuse A., Eguchi M., Hayashi Y., Sugita K., Nakazawa S., Minato K., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. Establishment and characterization of a megakaryoblastic cell line (CMK) from a Down's syndrome patient with acute megakaryoblastic leukemia. British Journal of Haematology 1989; 72: 184–190
   PubMed Web of Science ®Google Scholar
• Greenberg S. M., Rosentha D. S., Greeley T. A., Tratravahi R., Hardin R. I. Characterization of a new megakaryocytic cell line: the Dami cell. Blood 1988; 72: 1968–1977
   PubMed Web of Science ®Google Scholar
• Ogura M., Morishima Y., Ohno R., Kato Y., Hirabayashi N., Nagura H., Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 1985; 66: 1384–1392
   PubMed Web of Science ®Google Scholar
• Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., Okada M., Sato H., Wada H., Yawata Y., Suda T., Miura Y. Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony-stimulating factor. Interleukin 3 or Erythropoietin for growth and survival. Cancer Research 1991; 51: 341–348
   PubMed Web of Science ®Google Scholar
• Tabilio A., Pelicci P., Vinci G., Mannin P., Civin C. J., Vainchenker W., Testa U., Lipinski M., Rochant H., Breton-Gorius J. Myeloid and megakaryocytic properties of K562 cell lines. Cancer Research 1983; 43: 4569–4574
   PubMed Web of Science ®Google Scholar
• Tabilio A., Rose J-P., Testa U., Kieffer N., Nurden A. T., Del Canizo M. C., Breton-Gorius J., Vainchenker W. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemic cell line (HEL). EMBO Journal 1984; 3: 453–459
   PubMed Web of Science ®Google Scholar
• Fraser J. K., Tan A. S., Lin F-K., Berridge M. V. Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp. Hematol. 1989; 17: 10–16
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Laver J. H., Kato T., Miyazaki H., Ogawa M. Recombinat human thrombopoietin (MPL Ligand) enhances proliferation of erythroid progenitors. Blood. 1995; 86, (supplement 1), 9a
   Google Scholar
• Yumura-Yagi K., Hara J., Kurahashi H., Nishiura T., Kaneyama Y., Osugi Y., Sakata N., Inoue M., Tawa A., Okada S., Kawa-Ha K. Mixed phenotype of blasts in acute megakaryocytic leukemia and transient abnormal myelopoiesis in Down's syndrome. British Journal of Haematology 1992; 81: 520–525
   PubMed Web of Science ®Google Scholar
• Cuneo A., Mecucci C., Kerim S., Vandenberghe E., Dal Cin P., Van Orshoven A., Rodhain J., Bosly A., Michaux J. L., Martiat P., Boogaerts M., Carli M. G., Castoldi G., Van Den Berghe H. Multiple stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74: 1781–1790
   PubMed Web of Science ®Google Scholar
• Kurtzburg J., Waldman T. A., Davey M. P., Brigner S. M., Moore J. O., Helshfield M. S., Haynes B. F. CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1987; 73: 381–390
   Web of Science ®Google Scholar
• Koike T., Aoki S., Maruyama S., Narita M., Ishizuka T., Imanaka H., Adachi T., Maeda H., Shibata A. Cell surface phenotyping of megakaryoblasts. Blood 1987; 69: 957–960
   PubMed Web of Science ®Google Scholar
• Suda T., Suda J., Miura Y., Hayashi Y., Eguchi M., Tadokoro K., Saito M. Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia. Blood 1985; 66: 1278–1283
   PubMed Web of Science ®Google Scholar
• Suda J., Eguchi M., Akiyama Y., Iwama Y., Furukawa T., Sato Y., Miura Y., Suda T., Saito M. Differentiation of blast cells from a Down's syndrom patient with transient myeloproliferative disorder. Blood 1985; 69: 508–512
   Web of Science ®Google Scholar
• San Miguel J. F., Gonzalez M., Canizo M. C., Ojoda E., Orfo A., Caballero M. D., Moro M. J., Fisec P., Lopez Borrasca A. Leukemias with megakaryoblastic involvement: Clinical, hematologic and immunologic characteristics. Blood 1988; 72: 402–407
   PubMed Web of Science ®Google Scholar
• Ito E., Kasai K., Hayashi Y., Toki T., Arai K., Yokoyama S., Kato K., Tachibana N., Yamamoto M., Yokoyama M. Expression of erythroid-specific genes in acute megakaryoblastic leukemia and transient myeloproliferative disorder in Down's syndrome. Brish Journal of Haematology 1995; 90: 607–614
   PubMed Web of Science ®Google Scholar
• Riddle R. D., Yamamoto M., Engel J. D. (1978) Expression of δ-aminolevulinate synthase in avian cells. Separate genes encode erythroid-specific and non specific isozymes. Proceedings of the National Academy of Science of the United States 1989; 86:792–796. 1989
   Google Scholar
• Okumura N., Tsuji K., Nakahata T. Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood 1992; 81: 642–650
   Google Scholar
• Leonard M., Brice M., Engel J. D., Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 1993; 82: 1071–1079
   PubMed Web of Science ®Google Scholar
• Nagai T., Harigae H., Iahihara H., Motoyoshi H., Minegishi N., Tsuchiya S., Hayasi N., Gu L., Andres B., Engel J. D., Yamamoto M. Transcription factor GATA-2 is expressed in erythroid. early myeloid and CD34+ human leukemia-derived cell lines. Blood 1994; 84: 1074–1084
   PubMed Web of Science ®Google Scholar
• Endo K., Harigae H., Nagai T., Fujie H., Meguro K., Watanabe N., Furuyama K., Kameoka J., Okuda M., Hayashi N., Yamamoto M., Abe K. Two chronic myelogenous leukemia cell lines which represent different stages of erythroid differentiation. British Journal of Haematology 1993; 85: 653–662
   PubMed Web of Science ®Google Scholar
• Yamamoto M., Ko L. J., Leonard M. W., Beug H., Orkin S. H., Engel J. D. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes and Development 1990; 4: 1650–1662
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Fladrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemias: A report of the French-American-British Cooperative Group. Annals of Internal Medicine 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Villeval J. L., Cramer P., Lemoine F., Henri A., Battaieb A., Bernaudin F., Beuzard Y., Berger R., Flandrin G., Breton-Gorius J., Vainchenker W. Phenotype of early erythroblastic leukemia. Blood 1986; 68: 1167–1174
   PubMed Web of Science ®Google Scholar
• Garand R., Duchayne E., Blanchard D., Robillard N., Kuhlein E., Fenneteau O., Salomon-Nguyen F., Grange M. J., Rousselot P., Demur C., Talmant P., Radford I., Flandrin G. The Group Francais d'Hematologie Cellulaire. Minimally differentiated erythroleukemia (AML M6 ‘variant’) a rare subset of AML distinct from AML M6. British Journal of Haematology 1995; 90: 868–875
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Sieff C., Edwards P. A. W. Monoclonal antiglycophorin as a probe for erythroleukemias. Blood 1983; 61: 645–651
   PubMed Web of Science ®Google Scholar
• Debili N., Keiffer N., Nakazawa M., Guichard J., Titeux M., Cramer E., Breton-Gorius J, Veinchenker W. Expression of platelet glycoprotein Ib by cultured human megakaryocytes: ultrastructual localization and biosynthesis. Blood 1990; 76: 368–376
   PubMed Web of Science ®Google Scholar
• McMichael A. J., Rust N. A., Pilch J. R., Solchynsky R., Morton J., Mason D. Y., Ruan C., Tobelen G., Caen J. Monoclonal antibody to human platelet glycoprotein I. I Immunological study. British Journal of Haematology 1981; 49: 501
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J. Phenotype of blasts in acute erythroblastic and megakaryoblastic leukemia-review. Keio J. Med. 1987; 36: 23–45
   PubMedGoogle Scholar
• Fraser J. K., Leahy M. F., Berridge M. V. Expression of antigens of the platelets glycoprotein IIb/IIIa complex on human hematopoietic stem cells. Blood 1986; 68: 762–769
   PubMed Web of Science ®Google Scholar
• Poli N., O'Brien N., Tarvares De Castro T., Matutes E., San Miguel J. F., Catovsky D. Characterization of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiation leukemia. British Journal of Haematology 1985; 59: 277
   PubMed Web of Science ®Google Scholar
• Deimann W., Seiz M., Gemsa D., Fahimi H. D. Endogenous peroxidase in the nuclear envelope and endoplasmic reticulum of human monocytes in vitro: association with arachidonic acid metabolism. Blood 1984; 64: 491–498
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J., Villeval J. L., Mitijavila M. T., Vinci G., Guichard H., Rochant G., Flandrin G., Veinchenker W. Ultrastructual and cytochemical characterization of blasts from early erythroblastic leukemia. Leukemia 1987; 1: 173–181
   PubMed Web of Science ®Google Scholar
• Cuneo A., Orshoven V., Michaux J. L., Boogaerts M., Louwagie A., Doyen C., Dal Cin P., Fagioli F., Castoldi G., Van Den Berghe H. Morphologic, immunologic and cytogenetic studies in erythroleukemia: evidence for multi lineage involvement and identification of two distinct cytogenetic-clinico-pathological types. British Journal of Haematology 1990; 75: 346–354
   PubMed Web of Science ®Google Scholar